AbbVie (ABBV)
(Delayed Data from NYSE)
$173.61 USD
+1.29 (0.75%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $173.95 +0.34 (0.20%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 26% (181 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.67 | 2.10 | 9.99 |
Current Quarter Estimate | 2.56 | 37.64 | 61.00 |
Year Ago Quarter Estimate | 2.91 | 11.39 | 54.84 |
Next Quarter Estimate | 2.90 | 34.85 | 63.00 |
Next Year Estimate | 12.13 | 178.47 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -2.70 | -0.90 | 15.67 |
Next Year | 12.21 | 15.80 | 9.31 |
Last 5 Years | 8.20 | 2.90 | 8.10 |
Next 5 Years | 7.30 | 12.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 15.72 | 15.53 |
Price/Book (MRQ) | 37.81 | 6.15 |
Price/Cash Flow (MRFY) | 10.90 | 10.87 |
Dividend Yield | 3.60% | 2.39% |
Net Profit Margin (TTM) | 11.02% | NA |
Return on Equity (TTM) | 179.47% | NA |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.